Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Pseudomonas Aeruginosa Infection”

34 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 34 results

Not applicableUnknownNCT04490447
What this trial is testing

Identification of Microbiome and Metabolome of Bronchiectasis in Chinese Population.

Who this might be right for
Bronchiectasis
Shanghai Pulmonary Hospital, Shanghai, China 160
Not applicableUnknownNCT02102152
What this trial is testing

Efficacy & Tolerability of Tobramycin Podhaler in Bronchiectasis Patients With Chronic Pseudomonas Aeruginosa Infection

Who this might be right for
Bronchiectasis With Chronic Infection With Pseudomonas Aeruginosa
Rabin Medical Center 40
Not applicableStudy completedNCT04970225
What this trial is testing

Cystic Fibrosis Blood Neutrophils

Who this might be right for
Cystic Fibrosis
Assistance Publique - Hôpitaux de Paris 47
Large-scale testing (Phase 3)Study completedNCT01111383
What this trial is testing

A Single Arm 48-Week Follow-on Safety Study to a Core Study Comparing the Efficacy and Tolerability of Tobrineb®/Actitob®/Bramitob® Versus TOBI®

Who this might be right for
Cystic Fibrosis
Chiesi Farmaceutici S.p.A. 209
Post-approval studies (Phase 4)Ended earlyNCT03262142
What this trial is testing

Targeted AntiBiotics for Chronic Pulmonary Diseases

Who this might be right for
COPDRespiratory Tract InfectionsPseudomonas Aeruginosa+2 more
Chronic Obstructive Pulmonary Disease Trial Network, Denmark 51
Not applicableUnknownNCT04803695
What this trial is testing

Role of Pseudomonas Aeruginosa Biofilms in Exacerbations in Patients With Bronchiectasis With and Without Chronic Obstructive Pulmonary Disease

Who this might be right for
BronchiectasisMicrobial ColonizationPseudomonas Aeruginosa+1 more
Hospital Clinic of Barcelona 96
Not applicableLooking for participantsNCT06931002
What this trial is testing

A Rhinovirus Challenge Study to Investigate Exacerbations and Immune Responses in Bronchiectasis

Who this might be right for
Bronchiectasis AdultBronchiectasis With Acute ExacerbationBronchiectasis With Chronic Infection With Pseudomonas Aeruginosa+2 more
Imperial College London 54
Testing effectiveness (Phase 2)Study completedNCT00777296
What this trial is testing

Multidose Safety and Tolerability Study of Dose Escalation of Liposomal Amikacin for Inhalation (ARIKACE™)

Who this might be right for
Cystic Fibrosis
Insmed Incorporated 66
Large-scale testing (Phase 3)Not Yet RecruitingNCT06815549
What this trial is testing

An Open Clinical Trial of the Safety and Efficacy of the Drug Fluorothiazinone, 300 Mg Tablets with the Participation of Adult Patients with Chronic Bacterial Cystitis"

Who this might be right for
P. AeruginosaBaumanniiKlebsiella Pneumonia+3 more
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 280
Testing effectiveness (Phase 2)Study completedNCT00786513
What this trial is testing

Use of a Biofilm Antimicrobial Susceptibility Assay to Guide Antibiotic Therapy

Who this might be right for
Cystic Fibrosis
The Hospital for Sick Children 134
Large-scale testing (Phase 3)Study completedNCT01315678
What this trial is testing

Study to Evaluate Arikayce™ in CF Patients With Chronic Pseudomonas Aeruginosa Infections

Who this might be right for
Pseudomonas Aeruginosa Infection
Insmed Incorporated 302
Not applicableStudy completedNCT02449031
What this trial is testing

Observational Study in Cystic Fibrosis Patients Using TOBI® PODHALER® or Other FDA Approved Inhaled Antipseudomonal Antibacterial Drugs

Who this might be right for
Pseudomonas Aeruginosa in Cystic Fibrosis
Mylan Inc. 409
Large-scale testing (Phase 3)Study completedNCT00885365
What this trial is testing

A Study Comparing the Efficacy and Tolerability of Tobrineb®/Actitob®/Bramitob® Versus TOBI®

Who this might be right for
Cystic Fibrosis
Chiesi Farmaceutici S.p.A. 324
Large-scale testing (Phase 3)Study completedNCT01404234
What this trial is testing

Safety of AZLI in Children With Cystic Fibrosis (CF) and Chronic Pseudomonas Aeruginosa in the Lower Airways

Who this might be right for
Cystic FibrosisPseudomonas Aeruginosa
Gilead Sciences 61
Post-approval studies (Phase 4)Study completedNCT00411736
What this trial is testing

Scandinavian Cystic Fibrosis Azithromycin Study

Who this might be right for
Cystic Fibrosis
Rigshospitalet, Denmark 45
Testing effectiveness (Phase 2)Study completedNCT00775138
What this trial is testing

Safety and Tolerability Study of 2 Dose Level of Arikayce™ in Patients With Bronchiectasis and Chronic Infection Due to Pseudomonas Aeruginosa.

Who this might be right for
Bronchiectasis
Insmed Incorporated 64
Testing effectiveness (Phase 2)Study completedNCT03905642
What this trial is testing

Study of Dose Escalation of Liposomal Amikacin for Inhalation (ARIKAYCE™) - Extension Phase

Who this might be right for
Cystic Fibrosis
Insmed Incorporated 49
Testing effectiveness (Phase 2)Study completedNCT06016088
What this trial is testing

A Double-Blind, Active-Controlled, Multiple-Ascending Dose Study of Aerosolized RSP-1502 in Subjects With CF and Chronic PA Lung Infection

Who this might be right for
Cystic Fibrosis LungRespiratory Infections, Recurrent, ChronicPseudomonas Aeruginosa
Respirion Pharmaceuticals Pty Ltd 71
Not applicableStudy completedNCT00153634
What this trial is testing

Standard vs. Biofilm Susceptibility Testing in Cystic Fibrosis (CF)

Who this might be right for
Cystic FibrosisChronic Bronchitis
Seattle Children's Hospital 75
Testing effectiveness (Phase 2)Study completedNCT00558844
What this trial is testing

Safety/Tolerability Study of Arikayce™ in Cystic Fibrosis Patients With Chronic Infection Due to Pseudomonas Aeruginosa

Who this might be right for
Cystic Fibrosis
Insmed Incorporated 41
Next Page